人类1型糖尿病中的小岛细胞:从最近的进展到新疗法 - - 一个基于研讨会的未来研究路线图
J Cantley1, D L Eizirik2, E Latres3
1School of Medicine, University of Dundee, Dundee, United Kingdom of Great Britain and Northern Ireland.
The Journal of endocrinology
|July 26, 2023
概括
早期的1型糖尿病 (T1D) 涉及胰腺β细胞和免疫系统之间的有害相互作用. 本综述强调了关于预防或逆转T1D的新疗法的研讨会发现,确定了有希望的结果和剩余的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 1型糖尿病 (T1D) 的发病包括胰腺β细胞和免疫系统之间的有害交叉对话.
- 将当前的知识转化为有效的T1D疗法是一个迫切的临床需求.
- 在JDRF-DiabetesUK-INNODIA-nPOD研讨会上,重点是人类T1D中的小岛细胞,将最近的进展与新的治疗策略相结合.
研究的目的:
- 为提供"人类T1D中的小岛细胞:从最近的进展到新疗法"研讨会上讨论的关键主题的概述.
- 突出有前途的研究成果,并确定T1D预防和治疗的未满足需求.
- 促进更好地了解T1D中小岛细胞和免疫系统之间的相互作用.
主要方法:
- 从专门的科学研讨会的演讲和讨论的回顾.
- 综合关于目前对T1D机制的理解的信息.
- 确定T1D的新兴治疗目标和方法.
主要成果:
- 在了解T1D早期阶段方面取得了重大进展.
- 目前正在探索几个有前途的治疗途径,以调节对β细胞的免疫反应.
- 确定了开发T1D疗法的关键知识缺口和挑战.
结论:
- 更深入地了解T1D中小岛 - 免疫对话对于治疗开发至关重要.
- 翻译性研究对于从基础科学发现转向临床应用至关重要.
- 需要进一步的研究来制定有效的预防或逆转T1D的策略.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin: Biosynthesis, Chemistry, and Preparation
432
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
432
Diabetes: Management and Pharmacotherapy
317
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
317
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


